Samsara Biocapital, L.P.
Samsara BioCapital · adviser of record: Samsara Biocapital, LLC · 2016 vintage
Samsara Biocapital, L.P. is a 2016 venture fund managed by Samsara BioCapital, with $310mm raised (Form D, amount sold). It reported $1.9bn in gross assets at year-end 2025, 6.13x its size, its highest reported value.
- Latest value held
- $1.9bn year-end 2025
- Peak
- $1.9bn year-end 2025
- Fund size
- $310mm Form D, amount sold
- Held vs. size
- 6.13x peak 6.13x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $1.9bn | 6.13x | +17% over 2 yrs |
| 2023 | $1.62bn | 5.23x | +19% |
| 2022 | $1.37bn | 4.41x | +20% |
| 2021 | $1.14bn | 3.67x | +18% |
| 2020 | $964mm | 3.11x | +123% |
| 2019 | $432mm | 1.39x | +7% |
| 2018 | $405mm | 1.31x | +31% |
| 2017 | $309mm | 1.00x | +2527% |
| 2016 | $11.8mm | 0.04x | – |
Other funds from Samsara BioCapital
- 565 SPV I, L.P. 2019
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-8756530482. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.